Antibody profiles in COVID-19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment.
Anil BagriRafael R de AssisCheng-Ting TsaiGraham SimmonsZhen W MeiMelissa Von GoetzMichelle GatmaitanMars StoneClara DiGermanioRachel MartinelliOrsolya DarstJowin RioverosPeter V RobinsonDawn C WardAlyssa ZimanDavid SeftelSaahir KhanMichael P BuschPhilip L FelgnerLaurence M CorashPublished in: Transfusion (2022)
The findings of this study support the selection of effective CCP combined with the use of A/UVA-PRT in the production of CCP for patients with COVID-19.